AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,000 | +50.0% | 1,979 | -14.9% | 0.00% | – |
Q2 2023 | $2,000 | 0.0% | 2,325 | +24.7% | 0.00% | – |
Q1 2023 | $2,000 | +100.0% | 1,865 | 0.0% | 0.00% | – |
Q4 2022 | $1,000 | 0.0% | 1,865 | -17.4% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 2,257 | +15.4% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 1,955 | -53.4% | 0.00% | – |
Q1 2022 | $5,000 | -86.1% | 4,192 | -55.6% | 0.00% | – |
Q4 2021 | $36,000 | +12.5% | 9,440 | +61.6% | 0.00% | – |
Q3 2021 | $32,000 | -99.6% | 5,843 | -99.3% | 0.00% | -100.0% |
Q2 2021 | $7,455,000 | +13454.5% | 838,548 | +19519.7% | 0.00% | – |
Q1 2021 | $55,000 | +96.4% | 4,274 | +112.4% | 0.00% | – |
Q4 2020 | $28,000 | +16.7% | 2,012 | +7.9% | 0.00% | – |
Q3 2020 | $24,000 | -29.4% | 1,865 | -2.6% | 0.00% | – |
Q2 2020 | $34,000 | +9.7% | 1,914 | -3.3% | 0.00% | – |
Q1 2020 | $31,000 | +10.7% | 1,979 | +43.3% | 0.00% | – |
Q4 2019 | $28,000 | +2700.0% | 1,381 | +2024.6% | 0.00% | – |
Q4 2018 | $1,000 | -83.3% | 65 | -48.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |